Mesenchymal Stem Cell-based Therapy and Female Infertility: Limitations and Advances
This review examines female reproductive disorders and current treatments, then evaluates recent advances in using mesenchymal stem cells for infertility and improving women's reproductive health.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper reviews female reproductive disorders that can cause infertility, including premature ovarian failure, polycystic ovary syndrome, endometriosis, and Asherman syndrome, and then evaluates advances in mesenchymal stem cell (MSC)-based therapy for improving reproductive health. It describes MSCs as multipotent cells with high proliferation and multidirectional differentiation potential, highlighting mechanisms such as cell homing, secretion of active factors, and immune regulation. The authors’ key emphasis is that MSCs have fewer ethical restrictions than embryonic stem cells and are therefore receiving attention as a cell-based gynecological treatment, while also framing the work as a synthesis of existing studies rather than presenting new experimental data or specific clinical outcomes. This paper is centrally about endometriosis in the context of female infertility causes, where it is listed among the disorders targeted by MSC-related infertility treatment advances.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
10,223 characters
· extracted from
oa-doi-fallback
· 2 sections
· click to expand
Abstract
Keywords
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- Adult stem cells in the endometrium via openalex
- Endometriosis and infertility: Insights into the causal link and management strategies via openalex
- Endometriosis in pregnancy via openalex
- Management of endometriosis-related infertility: Considerations and treatment options via openalex
- Menstrual physiology: implications for endometrial pathology and beyond via openalex
- Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility via openalex
- Ovulation suppression for endometriosis for women with subfertility via openalex
- Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle via openalex
- Using Mesenchymal Stem Cells to Treat Female Infertility: An Update on Female Reproductive Diseases via openalex
- W2790078242 via openalex
- W2790436657 via openalex
- W2790699611 via openalex
- W2791045294 via openalex
- W2792410134 via openalex
- W2795744290 via openalex
- W2800037789 via openalex
- W2801400869 via openalex
- W2805699190 via openalex
- W137945594 via openalex
- W628528011 via openalex
- W1937647947 via openalex
- W1964554602 via openalex
- W1965953554 via openalex
- W1999630856 via openalex
- W2003887958 via openalex
- W2010081066 via openalex
- W2015390290 via openalex
- W2019605249 via openalex
- W2020381871 via openalex
- W2023326351 via openalex
- W2025371271 via openalex
- W2033000623 via openalex
- W2036386857 via openalex
- W2038775969 via openalex
- W2039031583 via openalex
- W2039539873 via openalex
- W2041154873 via openalex
- W2046347487 via openalex
- W2046663172 via openalex
- W2060899360 via openalex
- W2061981400 via openalex
- W2075933572 via openalex
- W2078292875 via openalex
- W2081100505 via openalex
- W2092950961 via openalex
- W2099229475 via openalex
- W2103745164 via openalex
- W2109776466 via openalex
- W2111985781 via openalex
- W2114407371 via openalex
- W2117854436 via openalex
- W2118462479 via openalex
- W2131004666 via openalex
- W2144112640 via openalex
- W2145306368 via openalex
- W2148625728 via openalex
- W2149502249 via openalex
- W2154968546 via openalex
- W2158369920 via openalex
- W2281429363 via openalex
- W2301597926 via openalex
- W2301922197 via openalex
- W2308102273 via openalex
- W2308714122 via openalex
- W2328808046 via openalex
- W2381646039 via openalex
- W2472282471 via openalex
- W2475874939 via openalex
- W2521917870 via openalex
- W2528009933 via openalex
- W2560481173 via openalex
- W2570085465 via openalex
- W2580328223 via openalex
- W2593036422 via openalex
- W2621178796 via openalex
- W2626728691 via openalex
- W2663383923 via openalex
- W2732516376 via openalex
- W2810668594 via openalex
- W2811059483 via openalex
- W2840917343 via openalex
- W2889318982 via openalex
- W2894663353 via openalex
- W2898336519 via openalex
- W2899747185 via openalex
- W2901231939 via openalex
- W2901529367 via openalex
- W2902724233 via openalex
- W2903755418 via openalex
- W2905486435 via openalex
- W2906270235 via openalex
- W2909623329 via openalex
- W2910971031 via openalex
- W2910997840 via openalex
- W2919128039 via openalex
- W2922004805 via openalex
- W2922280011 via openalex
- W2924531568 via openalex
- W2926536388 via openalex
- W2941661312 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-07-26T06:08:39.051465+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-16T06:06:56.275654+00:00
- unpaywall
- last seen: 2026-07-26T06:48:27.953686+00:00